|
|
||||||||
Regular Article TA |
a Departments of Pharmacology,
b Obstetrics and Gynaecology,
c Microbiology and Immunology, and
d Perinatal Research Centre, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
ABSTRACT
The large increase in placental surface area and fetal villous vascular development in the third trimester of pregnancy requires degradation and reformation of the placental basal lamina. Degradation is carried out by matrix metalloproteinases (MMPs) secreted by adjacent cells. Although the gelatinases, MMP-2 and MMP-9, which are released by extravillous cytotrophoblasts (CTs) are believed to play crucial roles in early placental expansion, neither has been reported in third trimester villous trophoblasts nor has appropriate (basolateral) release of any MMP by the highly polarized syncytiotrophoblast (ST) been demonstrated. We demonstrated villous trophoblast expression of both MMP-2 and MMP-9 by in situ immunohistochemistry and by Western blot analysis and zymography of lysates and culture supernatants of highly purified villous CTs. We also found that epidermal growth factor (EGF)-stimulated CT differentiation into ST and stimulation by the phorbol diester, PMA, both increase MMP-9 secretion. The direction of MMP release was determined with confluent cultures of ST on porous membranes. We found that >90% of MMP-2 and MMP-9 were released from the basolateral surface. We conclude that villous STs express and release gelatinases from their basolateral surfaces in a regulated manner and suggest that such polarized release may be important to villous tissue remodeling.
1 This study was carried out with funds received from MRC grant MT-15479 to L.J.G. and 14074 to M.W.R. M.W.R is a Medical Research Council of Canada Scientist.
2 Correspondence: Larry Guilbert, Department of Medical Microbiology and Immunology, 6-25 HMRC, University of Alberta, Edmonton, AB, Canada T6G 2S2. FAX: 780 492 9828; larry.guilbert{at}ualberta.ca
This article has been cited by other articles:
![]() |
S. K. Park, Y. S. Hwang, K.-K. Park, H.-J. Park, J. Y. Seo, and W.-Y. Chung Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKC{delta}-mediated signaling in MCF-7 human breast cancer cells Carcinogenesis, July 1, 2009; 30(7): 1225 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Coppock, A. White, J. D. Aplin, and M. Westwood Matrix Metalloprotease-3 and -9 Proteolyze Insulin-Like Growth Factor-Binding Protein-1 Biol Reprod, August 1, 2004; 71(2): 438 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, D. F. Lewis, Y. Gu, Y. Zhang, J. S. Alexander, and D. N. Granger Placental Trophoblast-Derived Factors Diminish Endothelial Barrier Function J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2421 - 2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hube, P. Reverdiau, S. Iochmann, S. Trassard, G. Thibault, and Y. Gruel Demonstration of a Tissue Factor Pathway Inhibitor 2 Messenger RNA Synthesis by Pure Villous Cytotrophoblast Cells Isolated from Term Human Placentas Biol Reprod, May 1, 2003; 68(5): 1888 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hemmings and L. J. Guilbert Polarized Release of Human Cytomegalovirus from Placental Trophoblasts J. Virol., June 5, 2002; 76(13): 6710 - 6717. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mayers, T. Hurst, L. Puttagunta, A. Radomski, T. Mycyk, G. Sawicki, D. Johnson, and M. W. Radomski Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 746 - 752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |